SCHEMBL20847477

SCHEMBL20847477

Fc1c(F)c(F)c(SN(Cc2ccc(C(F)(F)F)cc2)C2CC2)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
PYCR1 P32322 1/20 0.37
HDAC6 Q9UBN7 3/20 0.36
HDAC8 Q9BY41 2/20 0.35
TAAR1 Q96RJ0 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
IDO1 P14902 4/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
BACE1 P56817 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20847650 0.84 ALDH1A1 (0.35) HDAC6HDAC8KDM4EALDH1A1
SCHEMBL20847604 0.84 SLC6A2 (0.38) SLC6A2SLC6A4PYCR1HDAC6HDAC8
SCHEMBL20847664 0.84 ESR1 (0.38) HDAC6HDAC8HDAC3HDAC11ALDH1A1
SCHEMBL20847602 0.82 AGER (0.38) SLC6A2SLC6A4HDAC6HDAC8HDAC3
SCHEMBL20847642 0.81 SLC6A4 (0.35) SLC6A2SLC6A4HDAC6HDAC8KDM4E
SCHEMBL20847669 0.81 AGER (0.40) SLC6A2SLC6A4HDAC6PSEN1PSEN2
SCHEMBL20847622 0.80 L3MBTL1 (0.40) PYCR1ALDH1A1
SCHEMBL20847740 0.80 NSD2 (0.47) SLC6A2SLC6A4
SCHEMBL20847575 0.79 AGER (0.42) SLC6A2SLC6A4PSEN1PSEN2APH1B
SCHEMBL20847775 0.79 KMT2A (0.44) HDAC6HDAC8HDAC3HDAC11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019056120-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2019-03-28 WO disclosed